查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
无引线空间製造商全球市场规模、份额、产业趋势分析报告：2023-2030 年按类型、最终用途、地区分類的展望与预测
市场调查报告书
商品编码
1384882

无引线空间製造商全球市场规模、份额、产业趋势分析报告：2023-2030 年按类型、最终用途、地区分類的展望与预测

Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By End-use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030
出版日期: | 出版商: KBV Research | 英文 199 Pages | 订单完成后即时交付

价格

到 2030 年，无引线太空船市场规模预计将达到 8.277 亿美元，预测期内市场CAGR率为 15.2%。

根据 KBV Cardinal 矩阵中发布的分析，美敦力公司 (Medtronic PLC) 和雅培实验室 (Abbott Laboratories) 是市场上的领先参与者。波士顿科学公司、Integer Holdings Corporation 和 Terumo Corporation 等公司是该市场的主要创新者。 2023 年 9 月，波士顿科学公司宣布收购Lillyvant Medsystems，这是一家专门从事脊椎疼痛治疗的私人医疗设备公司。此次收购将 Relievant Medsystems 经临床验证的技术与 Boston Scientific 的策略相结合，为需要个人化医疗的个人扩大了治疗选择。

COVID-19 的影响

疫情期间，许多医院和医疗机构推迟或取消了择期手术，以节省资源并降低病毒传播的风险。因此，无引线起搏器植入术已经减少，因为它通常被认为是一种选择性的、非紧急的手术。包括无引线起搏器在内的医疗设备的全球供应链因製造和运输的封锁和限製而受到干扰。这有可能延迟医疗设备的供应并阻止患者获得这些尖端技术。医疗保健提供者已指示资源和工作人员应对 COVID-19 病例激增的情况。这种对非新冠疫情卫生服务的注意力和资源的转移影响了无引线起搏器的普及和植入。

市场成长要素

微创手术需求不断成长

微创手术的发展减少了导线放置和手术切口的需要，降低了手术风险并提高了患者的舒适度。这种侵入性的减少不仅提高了病患的安全性，也缩短了復原时间。接受无引线心律调节器植入的患者住院时间较短，术后不适也较少。这种快速康復使患者能够快速恢復日常生活和活动。这些程序为获得医疗设施可能受到限制的偏远和农村医疗保健环境开闢了新的可能性。因此，对微创手术的需求迅速增加，推动市场扩张。

心律不整盛行率上升

心律不整盛行率的上升是多种因素的复杂组合，从人口变化到生活方式的选择，再到医疗保健的进步。高血压是心律不整的既定危险因子。高血压会导致心臟结构和电讯号发生变化，增加心律不整的可能性。同样，糖尿病与心律不整，特别是心房颤动的风险增加有关。此外，心律不整的盛行率并不限于特定年龄组，而是影响不同阶层的个体。所有年龄层患有心律不整的患者，从老年人到年轻人，都可以从这些设备中受益。因此，心律不整的日益普及正在推动对无引线起搏器的需求。

市场抑制因素

监管和报销挑战

监管挑战，例如医疗设备复杂且漫长的核准流程，可能会大大推迟无引线起搏器的推出。监管机构要求对安全性和有效性进行彻底评估，导致产品认证的时间更长。监管核准的延迟不仅使患者无法获得先进的医疗解决方案，还会增加製造商的上市时间，影响他们提供尖端设备的能力。这些设备的经济负担可能会阻止医疗保健提供者和患者选择无引线起搏器作为起搏解决方案，儘管它们具有潜在的好处。这种经济负担可能会阻止人们选择这些设备，特别是当有更具成本效益的替代疗法可用时。所有这些因素都会阻碍市场的成长。

按类型分類的展望

按类型划分，市场可分为 Micra 经导管起搏系统和其他系统。其他细分市场在2022年也获得了可观的市场成长。无引线心律调节器，包括 NanoStim 和 WiSE CRT 系统等设备，与传统引线心律调节器相比具有多种优势。 Nanostim 非常紧凑，大约有一个大维生素胶囊的大小。这种小尺寸可实现侵入性较小的手术，并实现更谨慎和舒适的植入。 WiSE CRT 系统专为心臟再同步治疗（一种心臟衰竭治疗方法）而设计。无需传统起搏导线即可提供心臟再同步的优点。 NanoStim 和 WiSE CRT 系统均具有显着优势，包括微创植入、紧凑设计、降低感染风险、美容功效和长电池寿命。

最终用途展望

依最终用途，市场分为医院和门诊病人。 2022 年，医院业务在市场中占据最大的收益占有率。医院可以更有效地分配资源，因为他们不需要专门的手术室或手术团队专用植入心律调节器。这可以节省成本并为其他重要的医疗程序释放资源。由于没有引线离开人体，因此几乎消除了与引线插入部位相关的感染疾病风险。医院可以受益于与设备相关的较低感染率。

区域展望

从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区的市场进行了分析。 2022 年，北美市场占据最大的收益占有率。在北美，对无引线起搏器的需求正在稳定成长。这些因素凸显了心臟起搏技术的发展以及心律不整治疗向更加以患者为中心、侵入性较小且技术先进的选择的转变。无引线心律调节器不需要引线，引线容易受到感染疾病。这项功能在北美等感染控制是重中之重的地区受到高度重视。

目录

第1章市场范围和调查方法

  • 市场定义
  • 目的
  • 市场范围
  • 分割
  • 调查方法

第2章市场概况

  • 主要亮点

第3章市场概况

  • 介绍
    • 概述
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场抑制因素

第4章竞争分析-世界

  • KBV Cardinal Matrix
  • 近期全产业策略发展
    • 伙伴关係、协作和协议
    • 产品发布和产品扩展
    • 收购和合併
    • 测试和核准
  • 关键成功策略
    • 主要策略
    • 重大策略倡议
  • 波特五力分析

第5章全球无引线心律调节器市场：按类型

  • 全球 Micra 经导管心律调节系统市场（按地区）
  • 世界其他市场：按地区

第6章全球市场：依最终用途分类

  • 全球医院市场：按地区
  • 全球门诊设施市场：按地区

第7章世界市场：按地区

  • 北美市场
  • 欧洲市场
  • 亚太市场
  • 拉丁美洲/中东/非洲市场

第8章公司简介

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co KG
  • Lepu Medical Technology Co, Ltd
  • Integer Holdings Corporation
  • MicroPort Scientific Corporation
  • OSYPKA AG
  • Terumo Corporation
  • EBR Systems, Inc

第9章市场成功的必要条件

The Global Leadless Pacemakers Market size is expected to reach $827.7 million by 2030, rising at a market growth of 15.2% CAGR during the forecast period.

European patients and healthcare providers are increasingly valuing minimally invasive procedures. Thus, the European region would register nearly 28% share of the market by 2030. The catheter-based implantation of leadless pacemakers eliminates the need for surgical pockets and leads, reducing pain, scarring, and recovery time. Europe possesses a well-developed healthcare infrastructure with advanced medical facilities and resources. Many outpatient facilities as well as hospitals in this region are equipped to perform leadless pacemaker implantations and provide necessary follow-up care.

The major strategies followed by the market participants are Mergers & Acquisitionas the key developmental strategy to keep pace with the changing demands of end users. For instance, In August, 2022, Medtronic plc completed the acquisition of Affera, Inc., expanding its cardiac ablation portfolio with the addition of a groundbreaking cardiac mapping and navigation platform, featuring a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution. Moreover, In April, 2023, Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company known for its innovative atherectomy system in the treatment of peripheral and coronary artery disease. This acquisition enhances Abbott's offerings for vascular disease treatment, incorporating CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow.

Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC and Abbott Laboratories are the forerunners in the Market. Companies such as Boston Scientific Corporation, Integer Holdings Corporation and Terumo Corporation are some of the key innovators in the Market. In September, 2023, Boston Scientific Corporation announced the acquisition of Relievant Medsystems, Inc., a privately held medical device company specializing in vertebrogenic pain treatment. This acquisition enables the integration of Relievant Medsystems' clinically backed technology with Boston Scientific's strategies, expanding treatment options for individuals in need of personalized care.

COVID-19 Impact

During the pandemic, many hospitals and healthcare facilities postponed or canceled elective procedures to free up resources and reduce the risk of virus transmission. This led to a decrease in leadless pacemaker implantations, as these procedures are often considered elective and non-urgent. The global supply chain for medical devices, including leadless pacemakers, experienced disruptions due to lockdowns and restrictions on manufacturing and transportation. This led to delays in the availability of devices and potentially impacted patients' access to these advanced technologies. Hospitals and healthcare providers redirected resources and staff to handle the surge of COVID-19 cases. This diversion of attention and resources from non-COVID medical services affected the promotion and implantation of leadless pacemakers.

Market Growth Factors

Growing demand for minimally invasive procedures

The development of minimally invasive procedures has decreased the need for lead placement and surgical incisions, lowering surgical risks and enhancing patient comfort. This reduction in invasiveness has not only translated into enhanced patient safety but also quicker recovery times. Patients undergoing leadless pacemaker implantation experience shorter hospital stays and reduced post-operative discomfort. This quick recovery benefits patients by allowing them to return to their daily routines and activities more swiftly. These procedures have opened up new possibilities for remote and rural healthcare settings, where access to healthcare facilities may be limited. As a result, the rapidly increasing demand for minimally invasive procedures will aid in the expansion of the market.

Rising prevalence of cardiac arrhythmias

The rising prevalence of cardiac arrhythmias is a complex interplay of multiple factors, from demographic changes to lifestyle choices and advances in healthcare. High blood pressure is a well-established risk factor for arrhythmias. It can lead to changes in the heart's structure and electrical signaling, increasing the likelihood of arrhythmias. Similarly, diabetes is associated with an increased risk of arrhythmias, particularly atrial fibrillation. Furthermore, the prevalence of arrhythmias is not limited to specific age groups; it affects individuals across various demographics. Patients of all ages who experience cardiac arrhythmias, from the elderly to younger individuals, can benefit from these devices. Therefore, the rising prevalence of arrhythmias is boosting the demand for leadless pacemakers.

Market Restraining Factors

Regulatory and reimbursement challenges

Regulatory challenges, such as the complex and lengthy approval process for medical devices, can significantly delay the introduction of leadless pacemakers. Regulatory agencies require thorough evaluations of safety and efficacy, leading to prolonged timeframes for product clearance. Delays in regulatory approval not only hinder patients' access to advanced medical solutions but also increase the time-to-market for manufacturers, impacting their ability to offer cutting-edge devices. The economic burden of these devices can deter both healthcare providers and patients from choosing leadless pacemakers as a pacing solution despite their potential benefits. Such financial burdens may discourage some individuals from opting for these devices, especially if more cost-effective alternatives are available. All these factors may hamper the growth of the market.

Type Outlook

Based on type, the market is bifurcated into micra transcatheter pacing system and others. The other segment procured a considerable growth rate in the market in 2022. Leadless pacemakers, including devices like Nanostim and WiSE CRT System, offer several benefits compared to traditional pacemakers with leads. Nanostim is remarkably compact, similar in size to a large vitamin capsule. This small size allows for a less invasive procedure and results in a more unobtrusive and comfortable implantation. The WiSE CRT System is designed for cardiac resynchronization therapy, a treatment for heart failure. It offers the benefits of cardiac resynchronization without the need for traditional pacing leads. Both Nanostim and the WiSE CRT System provide significant advantages, such as minimally invasive implantation, compact designs, reduced infection risk, cosmetic benefits, and long-lasting battery life.

End-use Outlook

On the basis of end-use, the market is divided into hospitals and outpatient facilities. The hospitals segment acquired the largest revenue share in the market in 2022. Hospitals can efficiently allocate resources, as there is no need for specialized surgical suites or surgical teams dedicated to pacemaker implantations. This can lead to cost savings and the reallocation of resources to other critical medical procedures. With no leads that exit the body, the risk of infections related to lead entry sites is virtually eliminated. Hospitals can benefit from reduced rates of device-related infections.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. The demand for leadless pacemakers is steadily increasing in North America due to several factors contributing to their growing adoption in the region. These factors highlight the evolving landscape of cardiac pacing technology and the shift towards more patient-centric, minimally invasive, and technologically advanced options for treating cardiac arrhythmias. Leadless pacemakers eliminate the need for leads that can be susceptible to infection. In regions like North America, where infection control is a priority, this feature is highly valued.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc.

Strategies Deployed in Leadless Pacemakers Market

Partnerships, Collaborations, and Agreements:

Jul-2022: Medtronic plc has formed a strategic partnership with CathWorks, a privately held company headquartered in Kefar Sava, Israel, investing up to $75 million and co-promoting the FFRangio System globally. The agreement included an option for Medtronic to acquire CathWorks based on milestones, with CathWorks having the right to compel the acquisition if Medtronic opts out.

Sep-2021: Terumo Cardiovascular partnered with Etiometry to provide enhanced monitoring insights for adult cardiac surgery patients. This collaboration expanded technologies and enabled the utilization of clinical-decision support tools throughout a patient's hospital stay, offering a more comprehensive view of critical data for improved and informed bedside decisions during the transition from the operating room to the ICU.

Product Launches and Product Expansions:

Feb-2022: Abbott Laboratories has revealed the world's first patient implants of a dual-chamber leadless pacemaker system in its AVEIR DR i2i™ pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker marks a notable technological milestone in leadless pacing, representing the first such occurrence globally within the pivotal trial.

Jan-2022: Medtronic received regulatory approval and launched the Micra AV Transcatheter Pacing System in Japan. This pacemaker was designed to treat patients with AV block, addressing impaired electrical signals between the heart's chambers. The Micra TPS is the world's first leadless pacemaker, with the initial version (Micra VR) approved in Japan in 2017 for patients requiring single-chamber pacing.

Jun-2021: Medtronic PLC has introduced the MICRA AV, a pacemaker smaller than conventional ones, offering a leadless and minimally invasive solution for patients with complete heart block. This innovation, following Medtronic's legacy of inventing and disrupting, provides a cosmetically invisible option for those in need.

Acquisition and Mergers:

Sep-2023: Boston Scientific Corporation has announced the acquisition of Relievant Medsystems, Inc., a privately held medical device company specializing in vertebrogenic pain treatment. This acquisition enables the integration of Relievant Medsystems' clinically backed technology with Boston Scientific's strategies, expanding treatment options for individuals in need of personalized care.

Apr-2023: Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company known for its innovative atherectomy system in the treatment of peripheral and coronary artery disease. This acquisition enhances Abbott's offerings for vascular disease treatment, incorporating CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow.

Aug-2022: Medtronic plc completed the acquisition of Affera, Inc., expanding its cardiac ablation portfolio with the addition of a groundbreaking cardiac mapping and navigation platform, featuring a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.

May-2022: Medtronic PLC completed the acquisition of Intersect ENT, integrating PROPEL and SINUVA into its portfolio. PROPEL implants, maintaining sinus patency and delivering steroids, and SINUVA implants, treating nasal polyps in ethmoid sinus surgery patients, are now part of Medtronic's offerings.

Feb-2022: Boston Scientific has completed the acquisition of Baylis Medical Company Inc. This integration enables Boston Scientific to incorporate Baylis platforms into its existing electrophysiology and structural heart offerings, reinforcing its position in the rapidly growing cardiology markets.

Sep-2021: Boston Scientific Corporation completed the acquisition of Devoro Medical, Inc., a developer of a medical device intended to restore blood flow. Through this acquisition, the WOLF Thrombectomy Platform was integrated into Boston Scientific's products. Additionally, this acquisition provided the physicians with the necessary tools needed for the treatment.

Trials and Approval:

Dec-2022: Biotronik SE & Co. KG has initiated the first patient enrollment in BIO-CONDUCT, an FDA-approved investigational device exemption (IDE) trial. The study examines the use of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area, a location not currently approved for the Solia S lead.

Dec2021: Boston Scientific Corporation has started the MODULAR ATP clinical trial to assess the mCRM Modular Therapy System, which includes the EMBLEM™ MRI S-ICD System and the EMPOWER™ MPS, aiming to be the first leadless pacemaker capable of delivering bradycardia pacing support and antitachycardia pacing (ATP).

Scope of the Study

Market Segments covered in the Report:

By Type

  • Micra Transcatheter Pacing System
  • Others

By End-use

  • Hospitals
  • Outpatient Facilities

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd
  • Integer Holdings Corporation
  • MicroPort Scientific Corporation
  • Osypka AG
  • Terumo Corporation
  • EBR Systems, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Leadless Pacemakers Market, by Type
    • 1.4.2 Global Leadless Pacemakers Market, by End-use
    • 1.4.3 Global Leadless Pacemakers Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Trials & Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Nov - 2023, Sep) Leading Players
  • 4.4 Porter's Five Forces Analysis

Chapter 5. Global Leadless Pacemakers Market, By Type

  • 5.1 Global Micra Transcatheter Pacing System Market, By Region
  • 5.2 Global Others Market, By Region

Chapter 6. Global Leadless Pacemakers Market, By End-use

  • 6.1 Global Hospitals Market, By Region
  • 6.2 Global Outpatient Facilities Market, By Region

Chapter 7. Global Leadless Pacemakers Market, By Region

  • 7.1 North America Leadless Pacemakers Market
    • 7.1.1 North America Leadless Pacemakers Market, By Type
      • 7.1.1.1 North America Micra Transcatheter Pacing System Market, By Country
      • 7.1.1.2 North America Others Market, By Country
    • 7.1.2 North America Leadless Pacemakers Market, By End-use
      • 7.1.2.1 North America Hospitals Market, By Country
      • 7.1.2.2 North America Outpatient Facilities Market, By Country
    • 7.1.3 North America Leadless Pacemakers Market, By Country
      • 7.1.3.1 US Leadless Pacemakers Market
        • 7.1.3.1.1 US Leadless Pacemakers Market, By Type
        • 7.1.3.1.2 US Leadless Pacemakers Market, By End-use
      • 7.1.3.2 Canada Leadless Pacemakers Market
        • 7.1.3.2.1 Canada Leadless Pacemakers Market, By Type
        • 7.1.3.2.2 Canada Leadless Pacemakers Market, By End-use
      • 7.1.3.3 Mexico Leadless Pacemakers Market
        • 7.1.3.3.1 Mexico Leadless Pacemakers Market, By Type
        • 7.1.3.3.2 Mexico Leadless Pacemakers Market, By End-use
      • 7.1.3.4 Rest of North America Leadless Pacemakers Market
        • 7.1.3.4.1 Rest of North America Leadless Pacemakers Market, By Type
        • 7.1.3.4.2 Rest of North America Leadless Pacemakers Market, By End-use
  • 7.2 Europe Leadless Pacemakers Market
    • 7.2.1 Europe Leadless Pacemakers Market, By Type
      • 7.2.1.1 Europe Micra Transcatheter Pacing System Market, By Country
      • 7.2.1.2 Europe Others Market, By Country
    • 7.2.2 Europe Leadless Pacemakers Market, By End-use
      • 7.2.2.1 Europe Hospitals Market, By Country
      • 7.2.2.2 Europe Outpatient Facilities Market, By Country
    • 7.2.3 Europe Leadless Pacemakers Market, By Country
      • 7.2.3.1 Germany Leadless Pacemakers Market
        • 7.2.3.1.1 Germany Leadless Pacemakers Market, By Type
        • 7.2.3.1.2 Germany Leadless Pacemakers Market, By End-use
      • 7.2.3.2 UK Leadless Pacemakers Market
        • 7.2.3.2.1 UK Leadless Pacemakers Market, By Type
        • 7.2.3.2.2 UK Leadless Pacemakers Market, By End-use
      • 7.2.3.3 France Leadless Pacemakers Market
        • 7.2.3.3.1 France Leadless Pacemakers Market, By Type
        • 7.2.3.3.2 France Leadless Pacemakers Market, By End-use
      • 7.2.3.4 Russia Leadless Pacemakers Market
        • 7.2.3.4.1 Russia Leadless Pacemakers Market, By Type
        • 7.2.3.4.2 Russia Leadless Pacemakers Market, By End-use
      • 7.2.3.5 Spain Leadless Pacemakers Market
        • 7.2.3.5.1 Spain Leadless Pacemakers Market, By Type
        • 7.2.3.5.2 Spain Leadless Pacemakers Market, By End-use
      • 7.2.3.6 Italy Leadless Pacemakers Market
        • 7.2.3.6.1 Italy Leadless Pacemakers Market, By Type
        • 7.2.3.6.2 Italy Leadless Pacemakers Market, By End-use
      • 7.2.3.7 Rest of Europe Leadless Pacemakers Market
        • 7.2.3.7.1 Rest of Europe Leadless Pacemakers Market, By Type
        • 7.2.3.7.2 Rest of Europe Leadless Pacemakers Market, By End-use
  • 7.3 Asia Pacific Leadless Pacemakers Market
    • 7.3.1 Asia Pacific Leadless Pacemakers Market, By Type
      • 7.3.1.1 Asia Pacific Micra Transcatheter Pacing System Market, By Country
      • 7.3.1.2 Asia Pacific Others Market, By Country
    • 7.3.2 Asia Pacific Leadless Pacemakers Market, By End-use
      • 7.3.2.1 Asia Pacific Hospitals Market, By Country
      • 7.3.2.2 Asia Pacific Outpatient Facilities Market, By Country
    • 7.3.3 Asia Pacific Leadless Pacemakers Market, By Country
      • 7.3.3.1 China Leadless Pacemakers Market
        • 7.3.3.1.1 China Leadless Pacemakers Market, By Type
        • 7.3.3.1.2 China Leadless Pacemakers Market, By End-use
      • 7.3.3.2 Japan Leadless Pacemakers Market
        • 7.3.3.2.1 Japan Leadless Pacemakers Market, By Type
        • 7.3.3.2.2 Japan Leadless Pacemakers Market, By End-use
      • 7.3.3.3 India Leadless Pacemakers Market
        • 7.3.3.3.1 India Leadless Pacemakers Market, By Type
        • 7.3.3.3.2 India Leadless Pacemakers Market, By End-use
      • 7.3.3.4 South Korea Leadless Pacemakers Market
        • 7.3.3.4.1 South Korea Leadless Pacemakers Market, By Type
        • 7.3.3.4.2 South Korea Leadless Pacemakers Market, By End-use
      • 7.3.3.5 Singapore Leadless Pacemakers Market
        • 7.3.3.5.1 Singapore Leadless Pacemakers Market, By Type
        • 7.3.3.5.2 Singapore Leadless Pacemakers Market, By End-use
      • 7.3.3.6 Malaysia Leadless Pacemakers Market
        • 7.3.3.6.1 Malaysia Leadless Pacemakers Market, By Type
        • 7.3.3.6.2 Malaysia Leadless Pacemakers Market, By End-use
      • 7.3.3.7 Rest of Asia Pacific Leadless Pacemakers Market
        • 7.3.3.7.1 Rest of Asia Pacific Leadless Pacemakers Market, By Type
        • 7.3.3.7.2 Rest of Asia Pacific Leadless Pacemakers Market, By End-use
  • 7.4 LAMEA Leadless Pacemakers Market
    • 7.4.1 LAMEA Leadless Pacemakers Market, By Type
      • 7.4.1.1 LAMEA Micra Transcatheter Pacing System Market, By Country
      • 7.4.1.2 LAMEA Others Market, By Country
    • 7.4.2 LAMEA Leadless Pacemakers Market, By End-use
      • 7.4.2.1 LAMEA Hospitals Market, By Country
      • 7.4.2.2 LAMEA Outpatient Facilities Market, By Country
    • 7.4.3 LAMEA Leadless Pacemakers Market, By Country
      • 7.4.3.1 Brazil Leadless Pacemakers Market
        • 7.4.3.1.1 Brazil Leadless Pacemakers Market, By Type
        • 7.4.3.1.2 Brazil Leadless Pacemakers Market, By End-use
      • 7.4.3.2 Argentina Leadless Pacemakers Market
        • 7.4.3.2.1 Argentina Leadless Pacemakers Market, By Type
        • 7.4.3.2.2 Argentina Leadless Pacemakers Market, By End-use
      • 7.4.3.3 UAE Leadless Pacemakers Market
        • 7.4.3.3.1 UAE Leadless Pacemakers Market, By Type
        • 7.4.3.3.2 UAE Leadless Pacemakers Market, By End-use
      • 7.4.3.4 Saudi Arabia Leadless Pacemakers Market
        • 7.4.3.4.1 Saudi Arabia Leadless Pacemakers Market, By Type
        • 7.4.3.4.2 Saudi Arabia Leadless Pacemakers Market, By End-use
      • 7.4.3.5 South Africa Leadless Pacemakers Market
        • 7.4.3.5.1 South Africa Leadless Pacemakers Market, By Type
        • 7.4.3.5.2 South Africa Leadless Pacemakers Market, By End-use
      • 7.4.3.6 Nigeria Leadless Pacemakers Market
        • 7.4.3.6.1 Nigeria Leadless Pacemakers Market, By Type
        • 7.4.3.6.2 Nigeria Leadless Pacemakers Market, By End-use
      • 7.4.3.7 Rest of LAMEA Leadless Pacemakers Market
        • 7.4.3.7.1 Rest of LAMEA Leadless Pacemakers Market, By Type
        • 7.4.3.7.2 Rest of LAMEA Leadless Pacemakers Market, By End-use

Chapter 8. Company Profiles

  • 8.1 Medtronic PLC
    • 8.1.1 Company overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
      • 8.1.5.3 Acquisition and Mergers:
      • 8.1.5.4 Geographical Expansions:
    • 8.1.6 SWOT Analysis
  • 8.2 Abbott Laboratories
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Acquisition and Mergers:
    • 8.2.6 SWOT Analysis
  • 8.3 Boston Scientific Corporation
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Product Launches and Product Expansions:
      • 8.3.5.3 Acquisition and Mergers:
      • 8.3.5.4 Trials & Approval:
    • 8.3.6 SWOT Analysis
  • 8.4 Biotronik SE & Co. KG
    • 8.4.1 Company Overview
    • 8.4.2 Recent strategies and developments:
      • 8.4.2.1 Trials & Approval:
    • 8.4.3 SWOT Analysis
  • 8.5 Lepu Medical Technology Co., Ltd
    • 8.5.1 Company Overview
    • 8.5.2 SWOT Analysis
  • 8.6 Integer Holdings Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 SWOT Analysis
  • 8.7 MicroPort Scientific Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 OSYPKA AG
    • 8.8.1 Company Overview
    • 8.8.2 SWOT Analysis
  • 8.9 Terumo Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
      • 8.9.5.2 Acquisition and Mergers:
    • 8.9.6 SWOT Analysis
  • 8.10. EBR Systems, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 SWOT Analysis

Chapter 9. Winning Imperatives of Leadless Pacemakers Market

LIST OF TABLES

  • TABLE 1 Global Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 2 Global Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 3 Partnerships, Collaborations and Agreements- Leadless Pacemakers Market
  • TABLE 4 Product Launches And Product Expansions- Leadless Pacemakers Market
  • TABLE 5 Acquisition and Mergers- Leadless Pacemakers Market
  • TABLE 6 Trials & Approvals- Leadless Pacemakers Market
  • TABLE 7 Global Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 8 Global Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 9 Global Micra Transcatheter Pacing System Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 10 Global Micra Transcatheter Pacing System Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 11 Global Others Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 12 Global Others Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 13 Global Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 14 Global Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 15 Global Hospitals Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 16 Global Hospitals Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 17 Global Outpatient Facilities Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 18 Global Outpatient Facilities Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 19 Global Leadless Pacemakers Market, By Region, 2019 - 2022, USD Thousands
  • TABLE 20 Global Leadless Pacemakers Market, By Region, 2023 - 2030, USD Thousands
  • TABLE 21 North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 22 North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 23 North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 24 North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 25 North America Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 26 North America Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 27 North America Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 28 North America Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 29 North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 30 North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 31 North America Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 32 North America Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 33 North America Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 34 North America Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 35 North America Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 36 North America Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 37 US Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 38 US Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 39 US Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 40 US Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 41 US Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 42 US Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 43 Canada Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 44 Canada Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 45 Canada Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 46 Canada Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 47 Canada Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 48 Canada Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 49 Mexico Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 50 Mexico Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 51 Mexico Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 52 Mexico Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 53 Mexico Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 54 Mexico Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 55 Rest of North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 56 Rest of North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 57 Rest of North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 58 Rest of North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 59 Rest of North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 60 Rest of North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 61 Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 62 Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 63 Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 64 Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 65 Europe Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 66 Europe Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 67 Europe Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 68 Europe Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 69 Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 70 Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 71 Europe Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 72 Europe Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 73 Europe Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 74 Europe Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 75 Europe Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 76 Europe Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 77 Germany Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 78 Germany Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 79 Germany Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 80 Germany Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 81 Germany Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 82 Germany Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 83 UK Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 84 UK Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 85 UK Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 86 UK Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 87 UK Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 88 UK Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 89 France Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 90 France Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 91 France Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 92 France Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 93 France Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 94 France Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 95 Russia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 96 Russia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 97 Russia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 98 Russia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 99 Russia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 100 Russia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 101 Spain Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 102 Spain Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 103 Spain Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 104 Spain Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 105 Spain Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 106 Spain Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 107 Italy Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 108 Italy Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 109 Italy Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 110 Italy Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 111 Italy Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 112 Italy Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 113 Rest of Europe Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 114 Rest of Europe Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 115 Rest of Europe Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 116 Rest of Europe Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 117 Rest of Europe Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 118 Rest of Europe Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 119 Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 120 Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 121 Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 122 Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 123 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 124 Asia Pacific Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 125 Asia Pacific Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 126 Asia Pacific Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 127 Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 128 Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 129 Asia Pacific Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 130 Asia Pacific Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 131 Asia Pacific Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 132 Asia Pacific Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 133 Asia Pacific Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 134 Asia Pacific Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 135 China Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 136 China Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 137 China Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 138 China Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 139 China Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 140 China Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 141 Japan Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 142 Japan Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 143 Japan Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 144 Japan Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 145 Japan Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 146 Japan Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 147 India Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 148 India Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 149 India Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 150 India Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 151 India Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 152 India Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 153 South Korea Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 154 South Korea Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 155 South Korea Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 156 South Korea Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 157 South Korea Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 158 South Korea Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 159 Singapore Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 160 Singapore Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 161 Singapore Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 162 Singapore Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 163 Singapore Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 164 Singapore Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 165 Malaysia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 166 Malaysia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 167 Malaysia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 168 Malaysia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 169 Malaysia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 170 Malaysia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 171 Rest of Asia Pacific Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 172 Rest of Asia Pacific Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 173 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 174 Rest of Asia Pacific Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 175 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 176 Rest of Asia Pacific Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 177 LAMEA Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 178 LAMEA Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 179 LAMEA Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 180 LAMEA Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 181 LAMEA Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 182 LAMEA Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 183 LAMEA Others Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 184 LAMEA Others Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 185 LAMEA Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 186 LAMEA Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 187 LAMEA Hospitals Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 188 LAMEA Hospitals Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 189 LAMEA Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 190 LAMEA Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 191 LAMEA Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
  • TABLE 192 LAMEA Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
  • TABLE 193 Brazil Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 194 Brazil Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 195 Brazil Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 196 Brazil Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 197 Brazil Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 198 Brazil Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 199 Argentina Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 200 Argentina Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 201 Argentina Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 202 Argentina Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 203 Argentina Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 204 Argentina Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 205 UAE Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 206 UAE Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 207 UAE Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 208 UAE Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 209 UAE Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 210 UAE Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 211 Saudi Arabia Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 212 Saudi Arabia Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 213 Saudi Arabia Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 214 Saudi Arabia Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 215 Saudi Arabia Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 216 Saudi Arabia Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 217 South Africa Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 218 South Africa Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 219 South Africa Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 220 South Africa Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 221 South Africa Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 222 South Africa Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 223 Nigeria Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 224 Nigeria Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 225 Nigeria Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 226 Nigeria Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 227 Nigeria Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 228 Nigeria Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 229 Rest of LAMEA Leadless Pacemakers Market, 2019 - 2022, USD Thousands
  • TABLE 230 Rest of LAMEA Leadless Pacemakers Market, 2023 - 2030, USD Thousands
  • TABLE 231 Rest of LAMEA Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
  • TABLE 232 Rest of LAMEA Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
  • TABLE 233 Rest of LAMEA Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
  • TABLE 234 Rest of LAMEA Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
  • TABLE 235 Key Information - Medtronic PLC
  • TABLE 236 Key Information - Abbott Laboratories
  • TABLE 237 Key Information - Boston Scientific Corporation
  • TABLE 238 Key Information - Biotronik SE & Co. KG
  • TABLE 239 Key Information - Lepu Medical Technology Co., Ltd
  • TABLE 240 Key Information - Integer Holdings Corporation
  • TABLE 241 key Information - MicroPort Scientific Corporation
  • TABLE 242 Key Information - OSYPKA AG
  • TABLE 243 Key Information - Terumo Corporation
  • TABLE 244 Key Information - EBR Systems, Inc.